(Q33493278)

27 July 2017

title

Phase I and pharmacokinetic trial of liposome-encapsulated doxorubicin (English)

1 reference

27 July 2017

main subject

phase I clinical trial

0 references

1 reference

1 reference

B A Conley

1

1 reference

27 July 2017

M J Egorin

2

1 reference

27 July 2017

M Y Whitacre

3

1 reference

27 July 2017

D C Carter

4

1 reference

27 July 2017

E G Zuhowski

5

1 reference

27 July 2017

D A Van Echo

6

1 reference

27 July 2017

publication date

1 January 1993

1 reference

Cancer Chemotherapy and Pharmacology

27 July 2017

published in

1 reference

27 July 2017

volume

33

1 reference

27 July 2017

issue

2

1 reference

27 July 2017

page(s)

107-112

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00685327

27 July 2017

exact match

0 references

cites work

Facile and definitive determination of human adriamycin and daunoribicin metabolites by high-pressure liquid chromatography

1 reference

12 December 2020

A phase I clinical trial and pharmacokinetic evaluation of liposome-encapsulated doxorubicin

1 reference

12 December 2020

Sensitization of multidrug-resistant colon cancer cells to doxorubicin encapsulated in liposomes

1 reference

12 December 2020

Analysis of the effect of liposome encapsulation on the vesicant properties, acute and cardiac toxicities, and antitumor efficacy of doxorubicin

1 reference

12 December 2020

Alterations in murine host defense functions by adriamycin or liposome-encapsulated adriamycin

1 reference

12 December 2020

Pharmacokinetic and imaging studies in patients receiving a formulation of liposome-associated adriamycin

1 reference

12 December 2020

A comparative study on the antitumor effect, cardiotoxicity and nephrotoxicity of doxorubicin given as a bolus, continuous infusion or entrapped in liposomes in the Lou/M Wsl rat.

1 reference

12 December 2020

Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study

1 reference

12 December 2020

Prevention of chronic doxorubicin cardiotoxicity in beagles by liposomal encapsulation

1 reference

12 December 2020

The carrier potential of liposomes in biology and medicine (second of two parts)

1 reference

12 December 2020

Liposomes as carriers of antitumor agents: toward a clinical reality

1 reference

12 December 2020

Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times

1 reference

12 December 2020

Mlab — A mathematical modeling tool

1 reference

12 December 2020

Modulation of multidrug resistance in Chinese hamster cells by liposome-encapsulated doxorubicin

1 reference

12 December 2020

Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy

1 reference

12 December 2020

Superior therapeutic activity of liposome-associated adriamycin in a murine metastatic tumour model

1 reference

12 December 2020

Antitumor activity of liposome-encapsulated doxorubicin in advanced breast cancer: phase II study

1 reference

12 December 2020

Studies on the myelosuppressive activity of doxorubicin entrapped in liposomes

1 reference

12 December 2020

Method for rapid separation of liposome-associated doxorubicin from free doxorubicin in plasma

1 reference

12 December 2020

Uptake of antineoplastic agents into large unilamellar vesicles in response to a membrane potential

1 reference

12 December 2020

Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00685327

1 reference

Dimensions Publication ID

27 July 2017

1020441301

0 references

1 reference